Thursday, December 3, 2020

COVID-19 SeroHub Launch

u s department of health and human services - national institutes of health
national institute of biomedical imaging and bioengineering - listserv

COVID-19 SeroHub Online Dashboard

SARS-cov2

 

The COVID-19 SeroHub, developed in collaboration with the NCI, National Institute of Allergy and Infectious Diseases (NIAID), and the CDC aims to:

  • Systematically identify published and ongoing SARS-CoV-2 seroprevalence studies.
  • Offer an interactive dashboard to visualize SARS-CoV-2 seroprevalence estimates over time and by geography, population, and other factors.

COVID-19 SeroHub initially contains data from 40+ seroprevalence studies conducted in the U.S. by the CDC, NIH, state and local health departments, universities, and other sources. Studies will be added to the hub as they become available.

Please be sure to check the COVID-19 SeroHub regularly for updates and new data.

COVID-19 SeroHub
This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud, on behalf of: National Institute for Biomedical Imaging and Bioengineering · 9000 Rockville Pike, Building 31, Room 1C14, Bethesda, MD 20892 GovDelivery logo

 

at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

If you’re doing this - beware.

...